September 2011

Subscriptions

Features

Not for Our Eyes: Global Ocular Medications Not Available in America

Here’s a look at glaucoma and dry eye drugs that are commonly used outside of the United States.

Artificial Corneas: Where Are We Today?

Keratoprosthetic implants, along with new biocompatible materials, can offer corneal visual options to millions of patients in need.

When Conventional Lenses Fail

Today’s eye care practitioners can draw from a variety of scleral and hybrid lenses to best fit their patient’s contact lens needs.

Tools and Techniques: How to Satisfy the Presbyope

Shifting patient demographics require today’s practitioners to master both the science and the art of multifocal contact lens fitting.

Novel Approaches to Treating Presbyopia

As the presbyopic population grows to nearly 100 million in the U.S., new surgical solutions may offer hope to those who are seeking independence from their spectacle or contact lens corrections.

Departments

Derail Dropouts

The Future is Multifocal Lenses

Presbyopic correcting lenses can help practitioners deliver visual freedom to the next generation of contact lens wearers.

Down on the Pharm

Keep an Eye on Eylea

With an anticipated FDA decision this November, Eylea could soon hit the market.

Editorial

Beyond First Glance

As practitioners, it is our responsibility to look for common eye problems and the potential for associated morbidity of systemic complications.

Gas-Permeable Strategies

Tools and Techniques: How to Satisfy the Presbyope

Shifting patient demographics require today’s practitioners to master both the science and the art of multifocal contact lens fitting.

A Family History: Post-RK Vision Fluctuation

Scleral lenses may be the most comfortable option for post-RK patients facing vision fluctuations.

Lens Care Update

Connecting the Dots

With the introduction of new lens materials, researchers are investigating whether the disinfection capability of an MPS is affected by contact lenses.